specific stimuli. This phenomenon has been described for the upper as well as for Background -In the lower airways an association has been found between early the lower airways. [1][2][3][4] In the lower airways the immediate response to allergen challenge is phase reaction (EPR), late phase reaction (LPR), and bronchial hyperreactivity. often followed by a late phase response. This bronchial late phase reaction is associated with However, this association has not been shown for the upper airways in nasal pollen increased inflammation and bronchial hyperreactivity. [5][6] [7] [8] In the upper airways late phase challenge studies. A study was undertaken to determine whether the EPR, LPR, and responses have also been described.
son, and those with allergy to pets were only prechallenge lavages with isotonic saline solution to clear the nose from secretions and to included if they had no contact with pets.
Symptomatic medication for rhinitis was obtain baseline levels of mediators. To prevent nasal congestion due to allergen challenge oxywithdrawn -oral corticosteroids two months before the start of the study, astemizole six metazoline 0.1% (two 0.125 ml puffs) was applied in both nostrils. Five minutes later a nasal weeks, nasal or inhaled corticosteroids, disodium cromoglycate and nedocromil sodium lavage was performed just before the nasal challenge with PBS. A nasal lavage was perthree weeks, and antihistamines three days before the start of the study. Patients with nasal formed 10 minutes after PBS and after each allergen challenge, immediately before the subpolyposis and those who had undergone nasal surgery less than three months before the study sequent challenge. Subsequently, lavage fluid was obtained hourly from 0.5 to 9.5 hours after or who had had a nasal infection during the two weeks before the study or immunotherapy the last allergen challenge. Nasal lavages were performed with 10 ml isotonic saline solution in the past were excluded.
(0.9%) preheated to 37°C. In each nostril 5 ml saline was instilled with a pipette while the subject gently flexed his/her head backwards.   Patients were challenged with increasing doses After 10 seconds the lavage fluid was expelled and collected in tubes. This procedure has been of HDM extract. Symptom scores were recorded and nasal lavage fluid was obtained for shown to produce a mean (SD) recovery of 7.7 (1.2) ml.
14 up to 9.5 hours after HDM challenge. Allergeninduced nasal hyperreactivity was determined by nasal histamine provocation 24 hours later. During the study patients were not allowed   any medication that affected nasal function. Symptoms were recorded using a scoring sysThe study was performed during the period tem according to Lebel et al 17 at the time points from January to August; this period was chosen of lavage. Symptom scores were graded in to minimise natural exposure to HDM. points as follows: 3-4 sneezes =1, [5 All patients gave their written informed con-sneezes =3; anterior rhinorrhoea =1; posterior sent and the study was approved by the medical rhinorrhoea =1; difficult nasal breathing =1; ethics committee of the University Hospital.
one nostril blocked =2; both nostrils blocked =3; pruritus of the nose =1; pruritus of the palate or ear =1; and conjunctivitis =       1 (total score 0-11). In addition, the number Challenges were performed in accordance with of sneezes and the amount of secretion were the methods described by Gerth van Wijk. 11 14 noted. Before starting the nasal challenges the patients Patients were divided into two groups acwaited for 30 minutes in order to give the nasal cording to their symptom scores: those with an mucosa time to acclimatise. Each patient was early response only (defined as early rechallenged with three increasing doses of HDM sponders) and those with both early and late extract (100, 1000 and 10 000 BU/ml; ALK phase symptoms (defined as dual responders). 14 Benelux, Groningen, The Netherlands) per-Patients whose symptom scores were above the formed at 10 minute intervals after challenge baseline level at two consecutive time pointswith phosphate buffered saline (PBS) con-that is, for at least one hour -between 3.5 and taining human serum albumin 0.03% and 9.5 hours were defined as dual responders. The benzalkonium chloride 0.05% (ALK Benelux). others with symptom scores equal to or lower The PBS and the different doses of HDM than the baseline score at 3.5-9.5 hours after extract were sprayed into each nostril by means challenge were assigned to the early responder of a nasal pump spray delivering a fixed dose group. The dual responder group included of 0.125 ml solution. The nasal response was patients with either a dual response or promeasured 10 minutes after each challenge, 30 longed/persistent response after challenge. The minutes after the last challenge (HDM period from 3.5 to 9.5 hours after challenge 10 000 BU/ml), and hourly for up to 9.5 hours was chosen because other investigators found after the last challenge. Nasal responsiveness a late phase nasal response in the same period. was monitored by the number of sneezes, the amount of secretion collected according to Borum, 16 and a symptom score according to Lebel et al. 17 
 
Lavage fluid was stored on ice, centrifuged for Nasal challenge with histamine phosphate (0.25, 0.50, 1.0, 2.0 and 4 mg/ml) was per-10 minutes at 400 g, and the supernatant stored at −20°C. Histamine levels were measured formed at five minute intervals after challenge with PBS. The amount of secretion, the num-with an automated fluorometric assay. 19 Tryptase and eosinophil cationic protein (ECP) were ber of sneezes, and the symptom score according to Lebel et al 17 were used as nasal determined by radioimmunoassay (RIA) according to the manufacturer's instructions response indicators.
(Pharmacia, Uppsala, Sweden), and albumin was determined by automatic kinetic nephelometry using an Array analyser (Beckmann,   Nasal lavages were performed as described by Mijdrecht, The Netherlands) according to the manufacturer's instructions. Naclerio et al. 18 This protocol comprises four   below the baseline levels, the individual peak levels during the LPR were compared with Patients were divided into the early (n=11) or dual responder group (n=13) according to the lowest levels after the EPR to measure recurrence of mediator influx during the LPR. their symptom scores. Differences between the groups in clinical response, mediators in lavage A two tailed p value of <0.05 was considered significant. fluid, and histamine responsiveness were tested with the non-parametric Mann-Whitney U test.
The correlation between the area under the curve (AUC) of symptom scores during the A two tailed p value of <0.05 was considered significant.
EPR (HDM 100, 1000, 10 000 BU/ml) and LPR (3.5-9.5 hours) and the AUC of the Mediator release/influx during the EPR and LPR was tested by the Wilcoxon test. Since histamine dose response was tested with the Spearman correlation test. the mediators decreased after the EPR, often group.bmj.com on June 24, 2017 -Published by http://thorax.bmj.com/ Downloaded from The mean symptom scores and mediator A recent study of patients allergic to HDM responders (n=11) showed an immediate response only. The dual responder group con-revealed a relation between pre-existing nasal hyperreactivity and LPR. 14 In view of this findsisted of 10 patients with a dual response and three patients with a prolonged response. The ing, we wanted to investigate in more detail the relation between EPR, LPR, inflammation, symptom scores and, to a lesser extent, the sneezing and secretory responses of the dual and nasal hyperreactivity in patients allergic to HDM. Patients were challenged with high responder group were significantly higher at most time points than those of the early re-doses of HDM extract in order to obtain maximal nasal response. We did not challenge each sponder group (fig 1A-C) .
Both early and dual responders showed a patient with their individual threshold dose to induce a particular nasal response. Because significant influx of albumin following challenge with HDM 10 000 BU/ml and during the we were interested in a spectrum of EPRs to investigate whether the intensity of the EPR is LPR. Albumin influx in the dual responder group was significantly higher during both the related to the presence of an LPR and increased hyperreactivity, each patient was challenged early and late phase than in the early responder group (fig 2A) . Patients in both groups showed with the same doses of HDM to obtain a range of EPRs. a significant increase in ECP release during the LPR. ECP release during the late phase To define the late phase reaction in the nose is difficult. Mygind et al 20 could not detect late response was significantly higher at 9.5 hours and tended to be higher at 4.5 hours (p=0.06) phase reactions by means of symptom scores.
In other studies in pollen sensitive patients in the dual responder group (fig 2B) . During the EPR a significant release of tryptase was late phase reactions have been determined by measurement of nasal obstruction and analysis detected in the dual responders only. The high mean (SE) values at 100 BU/ml HDM are of nasal lavage fluid. 10 21 We assigned patients to an early or dual responder group according largely due to one patient. Both groups showed a significant increase in tryptase release during to their symptom scores during the late phase period; this approach has been used in other the late phase period. Since the individual patients showed only short and small peak studies. 14 22 A comparison of the clinical responses in levels during the LPR, and as the individual peak levels were distributed at variable time the two groups showed that the immediate response was significantly higher in the dual points, these small individual tryptase peaks were levelled by presenting them as mean values responder group. In addition, the AUC of the symptom scores during the EPR and LPR were as in fig 2C. Dual responders showed a significantly higher release of tryptase following significantly correlated, which implies that a strong immediate response is necessary to inchallenge with HDM in a concentration of 10 000 BU/m and at 0.5 hours (fig 2C) . duce a late phase response. Small et al 23 recently found that the amounts of LTC 4 and PGD 2 Nasal responsiveness to histamine, as measured by the symptom score, was significantly during the EPR and LPR were correlated in a pollen challenge study, which also suggests a higher in the dual responder group (fig 3A) . Although graphically the baseline scores are relation between the two phases. However, nasal symptoms during the EPR and LPR were different, statistically no significant difference was shown. When correcting for the baseline, not correlated.
Albumin, being the major protein in plasma, dual responders still showed significantly increased symptom scores to all histamine doses. can be used as a marker of increased vasopermeability. 24 25 Albumin influx into nasal The number of sneezes of the dual responders was significantly higher at 0.5 mg/ml and ten-lavage fluid showed a pattern comparable with the symptom score: a dual response in the dual ded to be higher at 0.25 mg/ml (p=0.09) and 4.0 mg/ml (p=0.07; fig 3B) . The secretory responder group and an immediate response only in the early responder group. However, response tended to be stronger at 0.5 mg/ml (p=0.07) and was significantly stronger at the individual early responders also had small albumin peak levels. Since these individual small two highest histamine doses (fig 3C) . 
